Injectable intraocular corticosteroids

Paul A. Kurz, Eric B. Suhler, Christina J. Flaxel, James T. Rosenbaum

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Scopus citations


Although risks are present, intravitreal corticosteroid injection is a relatively safe and effective treatment in a variety of conditions. Risks of intravitreal steroid injection include, but are not limited to, elevation of intraocular pressure, infection, cataract, retinal detachment, and central retinal artery occlusion. Although most observations regarding intravitreal corticosteroid injection derive from treating diabetic macular edema and age-related macular degeneration, this approach is beneficial in a number of uveitic conditions.

Original languageEnglish (US)
Title of host publicationSurgical Management of Inflammatory Eye Disease
PublisherSpringer Berlin Heidelberg
Number of pages12
ISBN (Print)9783540338611
StatePublished - 2008

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Injectable intraocular corticosteroids'. Together they form a unique fingerprint.

Cite this